ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,629.00
0.55%
S&P ASX All Technology
3,016.30
1.48%
Brent Oil
82.765
0.00%
US Dollar vs AUD
1.514
-0.05%
Bitcoin
63,649.98
1.21%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX
  6. iBio Inc (IBIO)

  7. iBio Inc (IBIO) News

IBIO iBio Inc

1.9519
-0.0781 (-3.85%)
04 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
iBio Inc IBIO AMEX Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
-0.0781 -3.85% 1.9519 09:27:18
Open Price Low Price High Price Close Price Previous Close
2.03 1.95 2.15 1.99 2.03
more quote information »

Recent News

Date Time Source Heading
27/3/202422:00GLOBEiBio and AstralBio Announce Transformative AI drug discovery..
27/3/202410:35GLOBEiBio Announces $15.0 Million Private Placement
26/2/202423:59EDGAR2Form 8-K - Current report
26/2/202423:45GLOBEiBio Announces Sale of Preclinical PD-1 Agonist Antibody..
22/2/202408:55EDGAR2Form 8-K - Current report
20/1/202408:36EDGAR2Form 8-K - Current report
17/1/202400:15GLOBEiBio Announces Participation in 23rd Annual PepTalk..
11/1/202405:24EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/1/202408:30EDGAR2Form 8-K - Current report
05/1/202400:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
26/12/202323:44EDGAR2Form 8-K - Current report
26/12/202323:15GLOBEiBio Amends and Extends Maturity of Credit Agreement
09/12/202308:17EDGAR2Form 8-K - Current report
07/12/202301:13EDGAR2Form 8-K - Current report
07/12/202300:59EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
06/12/202300:00GLOBEiBio, Inc. Announces Pricing of $4.5 Million Public Offering
05/12/202316:15EDGAR2Form EFFECT - Notice of Effectiveness
01/12/202300:55EDGAR2Form S-1/A - General form for registration of securities..
29/11/202300:36EDGAR2Form 8-K - Current report
28/11/202309:20GLOBEiBio Announces Reverse Stock Split
04/11/202307:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202323:24GLOBEiBio Further Expands Tech Stack with ShieldTx™; Enhances..
28/10/202307:29EDGAR2Form S-1 - General form for registration of securities under..
26/10/202323:20EDGAR2Form DEF 14A - Other definitive proxy statements
17/10/202307:59EDGAR2Form PRE 14A - Other preliminary proxy statements
10/10/202323:56EDGAR2Form 8-K - Current report
10/10/202323:00GLOBEiBio to Highlight Technology for Advancing Discovery of..
06/10/202307:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202307:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202307:34EDGAR2Form 8-K - Current report
02/10/202321:45GLOBEiBio Explains Recent Filing of Registration Statement
30/9/202307:28EDGAR2Form POS AM - Post-Effective amendments for registration..
28/9/202306:31EDGAR2Form 8-K - Current report
28/9/202306:19GLOBEiBio Announces Filing of 2023 Annual Report on SEC Form 10-K
28/9/202306:01EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22/9/202306:05GLOBEiBio Announces Amendment to Credit Agreement with Woodforest
21/9/202322:00EDGAR2Form 8-K - Current report
31/8/202306:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/8/202306:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/8/202306:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202306:15GLOBEiBio Reports Triple Milestone: In Vivo Proof-of-Concept for..
15/8/202305:21EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
08/8/202306:01EDGAR2Form 8-K - Current report
07/8/202323:29EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
05/8/202306:47EDGAR2Form 8-K - Current report
29/7/202306:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/7/202306:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/7/202322:29EDGAR2Form 8-K - Current report
27/6/202322:00GLOBEiBio Appoints Dr. Martin Brenner as CEO, Felipe Duran as CFO..
13/6/202306:15GLOBEiBio Forges Research Collaboration with the National..

Your Recent History

AMEX
IBIO
iBio
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved